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Dapsone: A Sticky Solution for Neutrophil Adhesion 
Dapsone provides effective therapy for skin diseases in which there 
is deposition of immunoglobulin accompanied by an accumulation 
of neutrophils; for example, bullous pemphigoid, bullous lupus ery-
thematosus, and linear IgA bullous dermatosis. Although dapsone 
disrupts several metabolic functions in neutrophils, it also inhibits 
accumulation of these cells in the skin. Neutrophils express Fc re-
ceptors for both IgG and IgA. A neutrophil adhesion assay showed 
binding of neutrophils to these antibodies accumulated in the base-
ment membrane zones of skin sections from patients with bullous 
pemphigoid and linear IgA bullous dermatosis. A modification of 
this assay was used by Zone and his co-workers (Nguyen, p. 349) to 
examine the mode of action of dapsone. They used human skin 
sections incubated with sera containing IgG or IgA antibodies from 
bullous pemphigoid or linear IgA bullous dermatosis patients as a 
substrate for neutrophil binding. Dapsone-treated neutrophils 
showed a dose-dependent inhibition of cellular binding to the im-
mobilized immunoglobulins. Further, when antiserum isolated 
from a linear IgA bullous dermatosis patient under treatment with 
dapsone was used as a source ofIgA, neutrophil binding was consist-
ently reduced. Direct treatment of purified linear IgA bullous der-
matosis IgA with dapsone also produced a similar effect. 
The authors prorose that accumulation ofIgA is a primary event 
in development 0 cutaneous lesions in these dermatoses. Subse-
quent adherence of neutrophils to IgA is necessary for cellular locali-
zation and development of the skin lesions. Others noted that dap-
~one may re~ulate the extravasation of neutrophils by disrupting 
Integr.m-med~ated a~h~r~nce. Here we see that cellular binding to 
depOSits ofIg IS also mhlblted. Although the mechanism of action of 
da!:,sone is still unknown, re~ucing the localized binding of neutro-
phlls may account for the climcal efficacy of this drug in antibody-
mediated dermatoses. 
How Irritating Is the Vehicle? 
Retinoic acid (RA) is used or is under investigation in the treatment 
of acne, photoaging, skin carcinoma, and diseases of keratinization. 
Topical application of RA produces a pleiotropic response, as does 
administration of other compounds that act through nuclear 
steroid-like receptors. Among the obvious early effects are ery-
thema and scaling of the skin. There is a limited infiltration of 
inflammatory cells despite apparent irritation. RA treatment pro-
duces an increase in proliferation of dermal keratinocytes and an 
inhibition of their terminal differentiation. At least three high-
affinity RA receptors recognize genetic transcription response ele-
ments. Each RA-receptor complex probably activates induction of 
several genes in different tissues and different developmental 
growth programs. There are also cytoplasmic RA-binding proteins, 
CRABP-I and CRABP-II. Although these molecules have a high 
affinity for RA, their function is unknown. It is important to deter-
mine events within cells that are direct markers of retinoid action. 
This will provide an assay to screen for therapeutic retinoid com-
pounds with less irritating side effects. 
Previous studies have shown that RA treatment does not influ-
ence t.he levels .of RA rec~ptors in human keratinocytes. However, 
~here IS a selective expressIOn of CRABP-II in keratinocytes, which 
IS markedly Increased by RA treatment. Mice show similar cutane-
ous respo.nses aft~r inges.tion of retinoids. This suggested that the 
resp.onse IS retinOid-specific; however, non-specific irritants in the 
vehicle could be responsible. In this issue Elder et al (p. 356), using a 
broad d~se range,. ha~e c~mpared the cutaneous response to topical 
apphcatlOn of r~t1nolc aCid, sodium dedecyl sulfate (SDS), and the 
apphcatlon ve~lcle alone. They evaluated erythema, the histology 
~f punch bIOpSies, and the level of mRNA for CRABP-II, cyclophi-
lin, and the P-RA receptor in treated and untreated skin. In addition, 
they assayed mRNA levels after incubation of secondary cultures of 
dermal fibroblasts with these agents. They have clearly shown that 
erythema and histologic changes could be produced equally by 2% 
SDS and 0.1 % RA. However, a lOOO-times lower dose of RA than 
SDS elicited a potent increase in CRABP-II mRNA level. The 
effect was specific for this message because cyclophilin and RA 
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receptor mRNA levels were unaffected. A similar, specific induc-
tion was shown in the cultured dermal fibroblasts. This identifies 
"the CRABP-I1 mRNA response as a reliable, rapid, and selective 
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marker for retinoid activity, " and should provide a pharmaceuti-
cally useful system for further testing. 
Advances in Cultured Skin Substitutes: Control of Pigmentation and Keratinocyte Survival 
Many investigators have produced tissue analogues composed of 
combinations of cell types and implantable substrates that act as 
cultured skin substitutes. Skin heals well in the presence of these 
grafts, and both native and cultured skin grafts can reduce wound 
contraction. The use of keratinocyte sheets or composite grafts of 
cultured epithelium usually results in marked hypopigmentation of 
the regenerated skin. Not only is this a cosmetic problem, but the 
lack of pigment may leave basal cells of the skin unprotected and 
subject to damage from ultraviolet irradiation. Conversely, native 
skin grafts usually produce hyperpigmentation as a result of an 
increase in the number of melanosomes as well as melanocytes 
within the graft. Piebaldism, a locatized loss of pigment, has re-
sponded to the transplantation of cultured human melanocytes. In 
theory, addition of melanocytes to cultured skin substitutes should 
promote normal pigmentation of healed skin. 
In this issue Boyce et al (p. 360) have tested this idea with an 
interesting graft model using a cu ltured skin substitute. Grafts con-
tained human epidermal keratinocytes, melanocytes, and dermal 
fibroblasts grown on an acellular collagen-glycosaminoglycan sub-
strate. Independently cultured populations of cells were sequen-
tially plated. Fibroblasts grew on the porous side and a 1 :30 co-mix-
ture of melanocytes and keratinocytes attached to the non-porous 
side of the collagen-glycosaminoglycan support. The cultured skin 
substitute were established in keratinocyte growth medium, then 
divided into four equal pieces. Each portion was maintained in a 
different medium designed specifically for growth or differentia-
tion of a different cell type. The treated cultured skin substitute 
were grafted to full-thickness skin wounds on immune-deficient 
mice, protected with semipermeable wound dressings, and bathed 
with the keratinocyte growth medium. Two important findings 
emerged. Grafts grown in medium that promoted either the differ-
entiation ofkeratinocytes or the proliferation of melanocytes signifi-
cantly inhibited wound contraction and produced complete pig-
mentation compared with cultured skin substitute grafts from 
medium that promoted proliferation of keratinocytes or fibroblasts. 
Further, different pools of melanocyte cultures grew equally well, 
but produced different pigmentation, depending on their genetic 
origin. This model opens the door to more controlled studies of the 
cellular and humoral factors involved in wound healing, pigmenta-
tion disorders, and skin photobiology, and carcinogenesis in mela-
noma. In the future, melanocyte pigmentation may provide an im-
portant marker for direct observation of the progress of healing after 
skin grafting. 
The Presence of Anchoring Fibrils in Dystrophic Epidermolysis Bullosa 
During the past year, the Journal has reported several studies of the 
relationship between type VII collagen and various forms of epider-
molysis bullosa. Type VII collagen is the major component of the 
anchoring fibrils at the dermal/epidermal junction, and family stud-
ies have linked both dominant and recessive forms of epidermolysis 
bullosa to the Col7 A 1 gene located at chromosome 3p21. Quantita-
tive or qualitative disruption of type VII collagen production or inter-
ference with association of collagen molecules in these fibrils may 
contribute to the blistering characteristic of epidermolysis bullosa. 
In this issue, Eady and co-workers (McGrath et ai, p. 366) used 
silver-enhanced immunogold detection to examine anchoring fi-
brils in electron micrographs of skin from patients with various 
forms of dystrophic epidermolysis bullosa. Their intent was to pro-
vide better diagnostic criteria for epidermolysis bullosa as well as to 
learn more about the pathogenesis of these disorders. They used an 
antibody that recognizes the N-terminal portion of type VII colla-
gen, and therefore may detect partial peptide products. Micrographs 
show that even in patients with the most severe symptoms there is 
some expression of type VII collagen. Although sparse and re-
stricted to the lamina densa or located intracellularly, it is produced. 
Variability in the ultrastructural organization of the labeled fibrils is 
also present. The authors point out the necessity of defining new 
criteria for identification of anchoring fibrils. These criteria may 
include identifying molecules that the fibrils associate with in the 
basement membrane as well as specific posttranslational modifica-
tion of type VII collagen protein. 
Developmental Diversity in Desmosomes 
The desmosome is a structural element found at the cell surface in 
most epithelial tissues. It functions in cell-cell adhesion and shows 
cell type and tissue-specific heterogeneity. One of the major compo-
nents of desmosomes is the desmocollins. These glycoproteins are 
the products of at least two separate genes that each generate alterna-
tively spliced transcripts. Molecular cloning experiments show ho-
mology between desmocollins and the Ca++-depend,ent adhesion 
molecules known as cadherins. 
King et al (p. 373) developed a panel of antibodies that can dis-
criminate between the various forms of desmocollins on Western 
blots as well as on tissue sections. Here they show the complexity of 
desmocollin expression during epithelial keratinization as well as in 
cultured epidermal tissue. Calcium is an important trigger in the 
developmental program of keratinization. The domain recognized 
by one of the antibodies in this panel is sensitive to Ca++ at physio-
logic concentrations and may be involved in epidermal differentia-
tion. Although the role of Ca++ and desmocollins in stratification is 
not yet clear, this paper demonstrates that desmosomes represent a 
structural element that may have a role in epidermal differentiation. 
